உயிரியல் தொழில்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உயிரியல் தொழில்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உயிரியல் தொழில்கள் Today - Breaking & Trending Today

Sartorius Stedim Biotech : First-quarter results of Sartorius Stedim Biotech


Sales revenue up 61.1 percent to 655 million euros; underlying EBITDA margin 35.4 percent
A good 23 percentage points of growth contributed by the coronavirus pandemic
Accelerated expansion of production capacities in all regions on track as planned
Sartorius Stedim Biotech, a leading partner of the biopharma industry, had an exceptionally strong start to fiscal 2021 and grew substantially in order intake
1, sales revenue and earnings. This was fueled by strong fundamental growth, additional business from vaccine manufacturers, and acquisitions. 
Many of our products play an essential role in helping to overcome the pandemic. In addition to a very positive general business performance in the first quarter, we accordingly experienced strong demand for our products and technologies used in the production of vaccines and achieved a sharp increase in sales. The substantial rise in the company s profit margin was also supported by underproportionate devel ....

Puerto Rico , United States , South Korea , Provence Alpes Côd Azur , Petra Kirchhoff , Joachim Kreuzburg , Asia Pacific , Watersep Bioseparations , Head Of Corporate Communications Investor Relations , Sartorius Stedim Biotech Group , Danaher Corporation , Stedim Biotech , Sartorius Stedim Biotech , Middle East , European Summer Time , Performance Indicators , First Quarter , Biological Industries , North America , Corporate Communications , Investor Relations , Sartorius Stedim Biotech Stock Exchange , Press Release , 021 Dim Fr0013154002 , ப்வெர்டோ ரிக்கோ , ஒன்றுபட்டது மாநிலங்களில் ,

First-quarter results of Sartorius Stedim Biotech


Sales revenue up 61.1 percent to 655 million euros; underlying EBITDA margin 35.4 percent
A good 23 percentage points of growth contributed by the coronavirus pandemic
Accelerated expansion of production capacities in all regions on track as planned
Sartorius Stedim Biotech, a leading partner of the biopharma industry, had an exceptionally strong start to fiscal 2021 and grew substantially in order intake
1, sales revenue and earnings. This was fueled by strong fundamental growth, additional business from vaccine manufacturers, and acquisitions. 
Many of our products play an essential role in helping to overcome the pandemic. In addition to a very positive general business performance in the first quarter, we accordingly experienced strong demand for our products and technologies used in the production of vaccines and achieved a sharp increase in sales. The substantial rise in the company s profit margin was also supported by underproportionate devel ....

Puerto Rico , United States , South Korea , Provence Alpes Côd Azur , Petra Kirchhoff , Joachim Kreuzburg , Asia Pacific , Watersep Bioseparations , Head Of Corporate Communications Investor Relations , Sartorius Stedim Biotech Group , Danaher Corporation , Stedim Biotech , Sartorius Stedim Biotech , Middle East , European Summer Time , Performance Indicators , First Quarter , Biological Industries , North America , Corporate Communications , Investor Relations , Sartorius Stedim Biotech Sa , ப்வெர்டோ ரிக்கோ , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , பெட்ரா கர்க்‌ஹாஃப் ,